Doctor profile · Federal record
Dr. MUQDAD HASAN, MD
Student in an Organized Health Care Education/Training Program (CMS: ENDOCRINOLOGY) · NEW YORK, NY
- NPI 1588156558
- Accepts Medicare
- 28 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
DEPARTMENT OF INTERNAL MEDICINE, 1901, 1 ST AVENUE
NEW YORK, NY 100297491
(212) 423-6271
Credentials & registration
- NPI registered
- June 2018 — 8 yrs on file
- Year of graduation
- 1998 — 28 yrs since
- Specialty taxonomy
- 390200000X — NUCC code
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1588156558. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
160
Distinct HCPCS
6
Medicare allowed
$21,380
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99203 |
New patient office or other outpatient visit, 30-44 minutes | 46 | 46 | $124 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 23 | 21 | $100 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 23 | 23 | $137 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 23 | 22 | $186 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 23 | 14 | $85 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 22 | 22 | $183 |
In context: peer comparison
Among 87 peers in this city , average services per provider: 115. This provider delivers 1.4× the peer median.Open Payments
Industry payments received
All-time total
$408
Transactions
22
Manufacturers
8
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novo Nordisk Inc | 6 | $107.77 | |
| Lilly USA, LLC | 6 | $98.51 | |
| Corcept Therapeutics | 3 | $73.22 | |
| SANOFI-AVENTIS U.S. LLC | 2 | $39.86 | |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $32.56 | |
| Medtronic, Inc. | 1 | $23.82 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18.32 | |
| Embecta Corp. | 1 | $14.09 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
390
Patients
86
Total drug cost
$176,411
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Trulicity (Dulaglutide) | Brand | 53 | 12 | $62,314 |
| Levothyroxine Sodium | Generic | 44 | 18 | $708 |
| Metformin Hcl | Generic | 42 | 20 | $327 |
| Jardiance (Empagliflozin) | Brand | 34 | 0 | $26,880 |
| Alcohol Prep Pads (Alcohol Antiseptic Pads) | Brand | 26 | 0 | $198 |
| Alendronate Sodium | Generic | 23 | 0 | $397 |
| Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) | Brand | 23 | 11 | $7,124 |
| Ozempic (Semaglutide) | Brand | 23 | 0 | $27,145 |
| Methimazole | Generic | 22 | 12 | $369 |
| Atorvastatin Calcium | Generic | 19 | 0 | $337 |